immune checkpoint inhibitors

/Tag:immune checkpoint inhibitors

DIABETIC KETOACIDOSIS TRIGGERED BY PEMBROLIZUMAB IN A PATIENT WITH BLADDER CANCER

Case Presentation: We are presenting a case of a 71-year-old male patient with a history of hypertension, non-insulin dependent type 2 diabetes mellitus (DM) well controlled on metformin, and non-invasive high grade urothelial bladder cancer [...]

By | 2018-03-19T13:05:06+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on DIABETIC KETOACIDOSIS TRIGGERED BY PEMBROLIZUMAB IN A PATIENT WITH BLADDER CANCER